When should troponin I be repeated if the initial result is negative in a patient with suspected acute coronary syndrome?

When to Repeat Troponin I if Initially Negative

For high-sensitivity troponin I assays, repeat testing should occur at 1-3 hours after the initial sample; for conventional troponin assays, repeat at 3-6 hours after the initial measurement. 1

Timing Based on Assay Type

The 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guidelines provide clear, evidence-based intervals for serial troponin sampling 1:

• High-sensitivity troponin (hs-cTnI): Repeat at 1-3 hours after time zero (initial sample)
• Conventional troponin: Repeat at 3-6 hours after time zero

These intervals represent Class 1, Level B-NR recommendations, meaning they are strongly supported by multiple observational studies and should be implemented in all patients with suspected ACS requiring serial troponin measurements.

Accelerated Protocols for Low-Risk Patients

For carefully selected low-risk patients, even faster rule-out strategies are reasonable:

Single measurement approach (Class 2a recommendation): If a patient presents ≥3 hours after symptom onset with a normal ECG and hs-cTnI below the limit of detection at time zero, a single measurement is reasonable to exclude myocardial injury 1. This approach has demonstrated a negative predictive value of 99.6% for 30-day death or myocardial infarction 2.

0/1-hour protocol: The RAPID-TnT trial demonstrated that a 0/1-hour hs-cTnT protocol was non-inferior to standard 0/3-hour testing, enabling more rapid ED discharge (median 4.6 vs 5.6 hours) while maintaining safety 2. This protocol reduced functional cardiac testing (7.5% vs 11.0%) without increasing adverse outcomes.

0/2-hour protocol: ACEP clinical policy (2018) supports that negative serial high-sensitivity troponin at 0 and 2 hours in validated accelerated diagnostic pathways can predict low rates of 30-day MACE, allowing accelerated discharge 3.

Critical Caveats

Symptom timing matters: The single measurement strategy only applies to patients presenting ≥3 hours after symptom onset. Earlier presenters require serial sampling because troponin may not have risen yet 1, 4.

Risk stratification is essential: These accelerated protocols work best when integrated into clinical decision pathways (CDPs) that incorporate ECG findings, clinical risk scores (HEART, TIMI), and patient characteristics 3, 1. Do not rely on troponin alone.

Assay-specific thresholds: Each institution must implement protocols based on their specific troponin assay, as 99th percentile cutoffs and limits of detection vary significantly between manufacturers 3, 1.

Special Populations

Renal impairment: Patients with chronic kidney disease and chronically elevated troponin require additional markers (CK, CK-MB) and consecutive measurements at admission and 12 hours to identify acute changes 5.

Elderly and comorbid patients: Real-world ED populations with multiple comorbidities (heart failure, atrial fibrillation, chronic kidney disease) have higher rates of troponin elevation from non-ACS causes, decreasing positive predictive value and increasing the proportion classified in "gray zones" requiring 3-hour sampling 6.

Practical Algorithm

1. Time zero: Obtain initial hs-cTnI
2. If below limit of detection AND >3 hours from symptom onset AND low-risk features: Consider single measurement rule-out 1
3. If detectable but below 99th percentile OR <3 hours from symptoms: Repeat at 1-3 hours 1
4. If elevated but unclear acuity: Additional sampling at 3 hours may be necessary, particularly in patients with comorbidities 6
5. Conventional troponin users: Must wait 3-6 hours for repeat measurement 1